Your browser doesn't support javascript.
loading
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help.
Curran, Kevin J; Nikiforow, Sarah; Bachier, Carlos; Hsu, Yen-Michael; Maloney, David; Maus, Marcela V; McCarthy, Philip; Porter, David; Shi, Patricia; Shpall, Elizabeth J; William, Basem; Wacker, Kara; Warkentin, Phyllis; Heslop, Helen E.
Afiliación
  • Curran KJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Bachier C; Sarah Cannon Transplant and Cellular Therapy Program, St. David's Austin Medical Center, Austin, TX.
  • Hsu YM; Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA.
  • Maloney D; Division of Hematology and Oncology Fred Hutchinson Cancer Research Center, Seattle WA.
  • Maus MV; Cellular Immunotherapy Program Massachusetts General Hospital, Boston MA.
  • McCarthy P; Department of Medicine, Transplant and Cellular Therapy Program Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Porter D; Division of Hematology/Oncology, Department of Medicine and Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Shi P; New York Blood Center Clinical Apheresis and Cellular Therapy Laboratory, New York, NY.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • William B; OhioHealth Blood and Marrow Transplant Program, OhioHealth, Columbus, OH.
  • Wacker K; Foundation for the Accreditation of Cellular Therapy, Omaha, NE.
  • Warkentin P; Foundation for the Accreditation of Cellular Therapy, Omaha, NE.
  • Heslop HE; Pathology/Microbiology, University of Nebraska Medical Center, Omaha, NE.
Blood Adv ; 8(4): 1053-1061, 2024 Feb 27.
Article en En | MEDLINE | ID: mdl-37467016

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article
...